Disappointing jobs data sent the markets lower during the midday with the Dow plummeting 126 points to 17,649.  Nasdaq fell 38 points to 4,862.

On the upside

Shares of GoDaddy (NYSE: GDDY) surged in its market debut.

Bloomberg reported that Brazilian president Dilma Rousseff announced plans to renew confidence in Petrobras (NYSE: PBR) by releasing audited financial statements and enforcing stricter compliance of rules.

Trillium Therapeutics (Nasdaq: TRIL) priced its public offering of 1.52 million common shares at $19.50 per share.

On the downside

Shares of Vaalco Energy (NYSE: EGY) extended its losses.

Campus Crest Communities (NYSE: CCG) will not pay any dividends to common stockholders in 2015 and has suspended dividend payments on Series A Cumulative Redeemable Preferred Shares.
 
Coherus Biosciences (Nasdaq: CHRS) priced its public offering of more than 4.13 million common shares at the discounted price of $29 per share.

In the broad market, advancing issues outpaced decliners by a margin of 10 to 9 on the NYSE while decliners edged out advancers by more than 7 to 5 on Nasdaq. The broader S&P 500 dropped 13 points to 2054. Bitcoin slipped $2 to $241.
The nation's private employers added fewer than expected jobs in March sending the markets tumbling to a sharply lower open with the Dow plunging 151 points to 17,624.  Nasdaq dropped 43 points to 4,857.

On the upside

The Food and Drug Administration granted Fast Track designation to Dyax (Nasdaq: DYAX) for DX-2930 for the prevention of hereditary angioedema attacks after the company reported positive Phase 1b study results.

Billionaire investor Carl Icahn purchased 4.06 million shares of Voltari (Nasdaq: VLTC).

Sears Holdings (Nasdaq: SHLD) will raise $2.5 billion by selling its properties to a newly formed real estate investment trust.

On the downside

EveryWare Global (Nasdaq: EVRY) will file for prepackaged Chapter 11 bankruptcy.

UTi Worldwide (Nasdaq: UTIW) widened fourth quarter losses more than expected as revenue fell and lowered its full year earnings outlook prompting a downgrade.
 
CytoSorbents (Nasdaq: CTSO) widened losses for the 2014 year.

In the broad market, declining issues barely edged out advancers by a slim margin on the NYSE while decliners outpaced advancers by more than 7 to 5 on Nasdaq. The broader S&P 500 fell 14 points to 2053. Bitcoin slipped $2 to $241.
Crude oil prices dropped as nuclear negotiations with Iran extended beyond the original deadline. The markets slumped to close sharply lower the Dow collapsing 200 points to 17,776.  Nasdaq plunged 46 points to 4,900.

On the upside

Craig-Hallum initiated coverage of Cambrex (NYSE: CBM) with a Buy rating and a $50 price target.

MLV & Co. upgraded Coronado Biosciences (Nasdaq: CNDO) from a Hold rating to a Buy rating.

Piper Jaffray lifted its price target on J.C. Penney (NYSE: JCP) from $13 to $14.

On the downside

Shares of OvaScience (Nasdaq: OVAS) extended its losses.

SAIC (NYSE: SAIC) reported higher fourth quarter earnings and revenue that topped analyst estimates but the stock price dropped.
 
Concerns of a coal glut weighed down shares of Peabody Energy (NYSE: BTU).

In the broad market, declining issues outpaced advancers by a margin of more than 7 to 5 on the NYSE and by nearly 5 to 3 on Nasdaq. The broader S&P 500 tumbled 18 points to 2067. Bitcoin slipped $2 to $243.

Markets fall as crude oil retreats

|
Falling crude oil prices weighed the markets down during the midday with the Dow dropping 86 points to 17,889.  Nasdaq fell 18 points to 4,929.

On the upside

RADA Electronic Industries (Nasdaq: RADA) entered a strategic agreement with DRS Technologies to introduce RADA's tactical active electronically scanned array radar technology to North America.

E-Commerce China Dangdang (Nasdaq: DANG) reported sharply higher fourth quarter earnings that topped analyst estimates as revenue climbed.

Fourth quarter earnings climbed for Movado Group (NYSE: MOV) to surpass analyst expectations by a wide margin.

On the downside

Raptor Pharmaceutical (Nasdaq: RPTP) announced a public offering of $75 million worth of common stock.

Celladon (Nasdaq: CLDN) widened losses for the fourth quarter.
 
Shares of Ohr Pharmaceutical (Nasdaq: OHRP) continued falling.

In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by nearly 2 to 1 on Nasdaq. The broader S&P 500 fell 7 points to 2078. Bitcoin slipped $2 to $242.
The markets opened lower with the Dow tumbling 79 points to 17,896 as the deadline to reach a nuclear deal with Iran loomed.  Nasdaq lost 17 points to 4,929.

On the upside

Piper Jaffray upgraded Horizon Pharma (Nasdaq: HZNP) from a Neutral rating to an Overweight rating.

The U.S. Patent and Trademark Office issued a patent to Great Basin Scientific (Nasdaq: GBSN) for the company's method of isothermal helicase-dependent amplification using blocked primers.

Charter Communications (Nasdaq: CHTR) will acquire rival Bright House Networks in a cash and stock deal valued at approximately $10.4 billion.

On the downside

Synta Pharmaceuticals (Nasdaq: SNTA) priced its public offering of 22 million common shares at the discounted price of $1.75.

Teck Resources (NYSE: TCK) denied that it engaged in merger discussions with Antofagasta.
 
Vaalco Energy (NYSE: EGY) will plug and abandon the post-salt Kindele-1 well offshore Angola.

In the broad market, declining issues outpaced advancers by a margin of nearly 4 to 1 on the NYSE and by more than 3 to 1 on Nasdaq. The broader S&P 500 lost 8 points to 2077. Bitcoin slipped $3 to $242.
Corporate consolidations sparked a rally that sent the markets soaring to a sharply higher close with the Dow rocketing 263 points to 17,976.  Nasdaq leaped 56 points to 4,947.

On the upside

Bargain hunters lifted shares of Genetic Technologies (Nasdaq: GENE).

Ford (NYSE: F) introduced the revived Lincoln Continental Concept using patented technology from Research Frontiers (Nasdaq: REFR) for an SPD-SmartGlass electronically tinting sunroof.

Fortune Brands Home & Security (NYSE: FBHS) offered a premium of approximately $600 million in cash to buy Norcraft (NYSE: NCFT).

On the downside

H.C. Wainwright analyst Andrew S. Fein said that data from a small study that was released by OvaScience (Nasdaq: OVAS) last week was promising but that it was too early to determine the viability of the fertility treatment Augment.

RBC Capital Markets downgraded Oi SA (NYSE: OIBR) from a Sector Perform rating to an Underperform rating.
 
Shares of 500.com (NYSE: WBAI) extended its losses.

In the broad market, advancing issues outpaced decliners by a margin of nearly 3 to 1 on the NYSE and by more than 2 to 1 on Nasdaq. The broader S&P 500 soared 25 points to 2086. Bitcoin added $6 to $246.
Pending home sales surged more than expected to send the markets soaring during the midday with the Dow leaping 270 points to 17,982.  Nasdaq jumped 50 points to 4,941.

On the upside

Fujifilm Holdings will buy Cellular Dynamics International (Nasdaq: ICEL) for a premium of approximately $307 million in cash.

ChinaNet Online Holdings (Nasdaq: CNET) entered a service partner agreement with Baidu (Nasdaq: BIDU).

Barclays upgraded Analog Devices (Nasdaq: ADI) from an Equal Weight rating to an Overweight rating.

On the downside

Investors locked in profits on World Wrestling Entertainment (NYSE: WWE) after the entertainment company reported record attendance at Levi's Stadium and record company revenue for a live event for WrestleMania 31 on Sunday.

The Food and Drug Administration issued a Complete Response Letter to Adamis Pharmaceuticals (Nasdaq: ADMP) for its Pre-filled Single Dose Epinephrine Syringe.
 
Wunderlich Securities downgraded Breitburn Energy Partners (Nasdaq: BBEP) from a Hold rating to a Sell rating.

In the broad market, advancing issues outpaced decliners by a margin of 5 to 2 on the NYSE and by nearly 2 to 1 on Nasdaq. The broader S&P 500 soared 24 points to 2085. Bitcoin rose $3 to $243. 
A flurry of pharmaceutical acquisitions sent the markets soaring to a sharply higher open with the Dow jumping 257 points to 17,970.  Nasdaq surged 45 points to 4,936.

On the upside

United Health Group will acquire pharmacy benefits manager Catamaran (Nasdaq: CTRX) in a deal valued at approximately $12.8 billion.

Auspex Pharmaceuticals (Nasdaq: ASPX) agreed to be acquired by Teva Pharmaceuticals (NYSE: TEVA) in a transaction valued at approximately $3.5 billion.

Horizon (Nasdaq: HZNP) will pay a premium of approximately $1.1 billion in cash to buy Hyperion Therapeutics (Nasdaq: HPTX).

On the downside

BioDelivery Sciences International (Nasdaq: BDSI) reported disappointing results from a Phase 3 study of Clonidine Topical Gel to treat painful diabetic neuropathy.

Abbott Laboratories will sell 35 million common shares of Mylan (Nasdaq: MYL) that it holds.
 
Morgan Stanley downgraded Altera (Nasdaq: ALTR) from an Overweight rating to an Equal Weight rating.

In the broad market, advancing issues outpaced decliners by a margin of more than 4 to 1 on the NYSE and by nearly 7 to 2 on Nasdaq. The broader S&P 500 surged 21 points to 2082. Bitcoin added $2 to $242.

Higher close on M&A news

|
Merger and acquisition news lifted the markets to a higher close with the Dow rising 34 points to 17,712.  Nasdaq climbed 27 points to 4,891.

On the upside

The Wall Street Journal reported that Intel (Nasdaq: INTC) engaged in discussions to acquire Altera (Nasdaq: ALTR).

ChinaCache International (Nasdaq: CCIH) swung to a profit for the fourth quarter.

Bargain hunters continued to snap up shares of Advanced Micro Devices (Nasdaq: AMD).

On the downside

Falling crude oil prices weighed down shares of Energy XXI (Nasdaq: EXXI) and Magnum Hunter Resources (NYSE: MHR).

OvaScience (Nasdaq: OVAS) discussed pregnancy rates of women who received its AUGMENT treatment in a conference call with analysts.
 
MOL Global (Nasdaq: MOLG) fell to a loss for the fourth quarter.

In the broad market, advancing issues outpaced decliners by a margin of more than 3 to 2 on the NYSE and by 7 to 5 on Nasdaq. The broader S&P 500 rose 4 points to 2061. Bitcoin added $1 to $247.
The markets traded near the flatline during the midday with the Dow slipping a point to 17,676 as economic growth in the fourth quarter slowed.  Nasdaq rose 11 points to 4,874.

On the upside

Shares of Kraft Foods (Nasdaq: KRFT) continued climbing.

BlackBerry (Nasdaq: BBRY) reported an unexpected profit for the fourth quarter.

Fourth quarter earnings rose for Oxford Industries (NYSE: OXM) to beat analyst expectations.

On the downside

Falling steel consumption in China weighed down shares of Gerdau (NYSE: GGB).

Applied DNA Sciences (Nasdaq: APDN) priced its public offering of 3.82 million common shares at the discounted price of $3.00 per share.
 
Shares of SandRidge Energy (NYSE: SD) fell as crude oil prices retreated.

In the broad market, advancing issues outpaced decliners by a margin of more than 7 to 5 on the NYSE and by 10 to 9 on Nasdaq. The broader S&P 500 edged up a fraction to 2057. Bitcoin added $1 to $247.

Monthly Archives

Powered by Movable Type 5.12